Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Lothe

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cancer Research|June 13, 2000
DNA copy number changes in malignant ovarian germ cell tumorsS M Kraggerud, J Szymanska, V M Abeler, et al.
Cancer Research|December 15, 1993
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family historyR A Lothe, P Peltomäki, G I Meling, et al.
International Journal of Cancer|April 6, 2001
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinomaM K Gjertsen, T Buanes, A R Rosseland, et al.
International Journal of Molecular Medicine|September 20, 2001
A germline E-cadherin mutation in a family with gastric and colon cancerS Salahshor, H Hou, C B Diep, et al.
British Journal of Cancer|March 20, 2014
Prognostic impact of genomic instability in colorectal cancerT S Hveem, M A Merok, M E Pretorius, et al.
Genes, Chromosomes & Cancer|March 10, 1998
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellitesX P Zhou, J M Hoang, Y J Li, et al.
Genes and Immunity|July 1, 2011
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancerT H Ågesen, M Berg, T Clancy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
Prognostic markers for colorectal cancer: estimating ploidy and stromaH E Danielsen, T S Hveem, E Domingo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyR Dienstmann, M J Mason, F A Sinicrope, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative StudyB Iacopetta, A Russo, V Bazan, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cancer Research|June 13, 2000
DNA copy number changes in malignant ovarian germ cell tumorsS M Kraggerud, J Szymanska, V M Abeler, et al.
Cancer Research|December 15, 1993
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family historyR A Lothe, P Peltomäki, G I Meling, et al.
International Journal of Cancer|April 6, 2001
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinomaM K Gjertsen, T Buanes, A R Rosseland, et al.
International Journal of Molecular Medicine|September 20, 2001
A germline E-cadherin mutation in a family with gastric and colon cancerS Salahshor, H Hou, C B Diep, et al.
British Journal of Cancer|March 20, 2014
Prognostic impact of genomic instability in colorectal cancerT S Hveem, M A Merok, M E Pretorius, et al.
Genes, Chromosomes & Cancer|March 10, 1998
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellitesX P Zhou, J M Hoang, Y J Li, et al.
Genes and Immunity|July 1, 2011
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancerT H Ågesen, M Berg, T Clancy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 3, 2018
Prognostic markers for colorectal cancer: estimating ploidy and stromaH E Danielsen, T S Hveem, E Domingo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker studyR Dienstmann, M J Mason, F A Sinicrope, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative StudyB Iacopetta, A Russo, V Bazan, et al.
Pageof 8